4.5 Article

Astrocytic phosphorylation of PDK1 on Tyr9 following an excitotoxic lesion in the mouse hippocampus

期刊

BRAIN RESEARCH
卷 1533, 期 -, 页码 37-43

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.brainres.2013.08.028

关键词

PDK1; Epilepsy; Neurodegerative disease; Astrocyte; Phosphorylation; Cell signaling

资金

  1. Chungnam National University
  2. National Research Foundation of Korea (NRF)
  3. Korea Government (MEST) [2007-0054932, 2012R1A1A2004714, 2012M3A9B6055302]
  4. Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea
  5. National Research Foundation of Korea [2012R1A1A2004714] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

3-phosphoinositide-dependent kinase-1 (PDK1) is suggested to play important roles in the regulation of synaptic plasticity and neuronal cell survival in the mature CNS. Although few studies have investigated the roles of PDK1, little is known about PDK1 changes in glial cells under neuropathological conditions. In current report, phosphorylation of PDK1 was monitored specially on tyrosine residues, following the induction of an excitotoxic lesion in rat brain by using kainic acid administration. In injured hippocampal CA3 region, Tyr9 phosphorylation of PDK1 was increased from 4 h until 3 day post-injection. Double immunohistochemistry further evaluated that these phosphorylated forms of PDK1 were localized in astrocytes not other cells. Overexpression of unphosphorylatable mutant, PDK1-Y9F leads to inhibit Protein kinase B (PKB/Akt) activation and cAMP responsive element binding protein (CREB) phosphorylation. In conclusion, our results suggested for the first time that tyrosine phosphorylation of PDK1 is required for PKB and CREB activation in KA-mediated excitotoxic lesion in mouse brain. (C) 2013 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据